-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, VCuoxpTyi8DDhB03AB4XNcTo09XD+0+KvgyENl3TFzviqQBRZYNdYExq5jdlb34k TYKsxNkpD9pYy4eG8f3uNQ== 0001230295-08-000047.txt : 20080117 0001230295-08-000047.hdr.sgml : 20080117 20080117171224 ACCESSION NUMBER: 0001230295-08-000047 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080115 FILED AS OF DATE: 20080117 DATE AS OF CHANGE: 20080117 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000722104 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 133033811 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 BUSINESS PHONE: 7324189300 MAIL ADDRESS: STREET 1: ONE TOWER CENTER CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 FORMER COMPANY: FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CLEMENT CHRISTOPHER G CENTRAL INDEX KEY: 0001218808 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15313 FILM NUMBER: 08536716 MAIL ADDRESS: STREET 1: C/O BIOTECHNOLOGY GENERAL CORP STREET 2: ONE TOWER CENTER BLVD 14TH FLR CITY: EAST BRUNSWICK STATE: NJ ZIP: 08816 4 1 cle316.xml X0202 4 2008-01-15 0 0000722104 SAVIENT PHARMACEUTICALS INC SVNT 0001218808 CLEMENT CHRISTOPHER G C/O SAVIENT PHARMACEUTICALS, INC. ONE TOWER CENTER BLVD., 14TH FLOOR EAST BRUNSWICK NJ 08816 0 1 0 0 President & CEO Common Stock, $.01 par value per share 2008-01-15 4 M 0 3000 2.7800 A 254569 D Common Stock, $.01 par value per share 2008-01-15 4 S 0 3000 21.3500 D 251569 D Common Stock, $.01 par value per share 2008-01-15 4 M 0 2000 2.9700 A 253569 D Common Stock, $.01 par value per share 2008-01-15 4 S 0 2000 21.3696 D 251569 D Common Stock, $.01 par value per share 2008-01-16 4 M 0 5000 2.9700 A 256569 D Common Stock, $.01 par value per share 2008-01-16 4 S 0 5000 21.2400 D 251569 D Common Stock, $.01 par value per share 2008-01-17 4 M 0 5000 2.9700 A 256569 D Common Stock, $.01 par value per share 2008-01-17 4 S 0 5000 20.2900 D 251569 D Option to Purchase Common Stock, $.01 par value 2.9700 2008-01-15 4 M 0 2000 2.9700 D 2004-01-22 2013-01-22 Common Stock, $.01 par value per share 2000 60500 D Option to Purchase Common Stock, $.01 par value 2.7800 2008-01-15 4 M 0 3000 2.7800 D 2006-04-12 2015-04-12 Common Stock, $.01 par value per share 3000 25000 D Option to Purchase Common Stock, $.01 par value 2.9700 2008-01-16 4 M 0 5000 2.9700 D 2004-01-22 2013-01-22 Common Stock, $.01 par value per share 5000 55500 D Option to Purchase Common Stock, $.01 par value 2.9700 2008-01-17 4 M 0 5000 2.9700 D 2004-01-22 2013-01-22 Common Stock, $.01 par value per share 5000 50500 D This sale was made pursuant to a trading plan adopted on June 14, 2007 by the reporting person in accordance with Rule 105b-1 under the Securities Exchange Act of 1934. Represents the average sale price. The highest price at which shares were sold was $21.3501 and the lowest price at which shares were sold was $21.35. Represents the average sale price. The highest price at which shares were sold was $21.3701 and the lowest price at which shares were sold was $21.36. By: /s/ Irina Azer as Attorney-In-Fact for 2008-01-17 -----END PRIVACY-ENHANCED MESSAGE-----